Table 1.
Acute effects of fluoxetine on brain indoleamine levels in trkB.T1 transgenic mice
Wild type | Transgenic | |||
---|---|---|---|---|
Saline | Fluoxetine | Saline | Fluoxetine | |
5-HT (nmol/gm tissue) | ||||
Frontal cortex | 2.31 ± 0.12 | 2.86 ± 0.17* | 2.05 ± 0.21 | 2.67 ± 0.11* |
Cingulate cortex | 1.57 ± 0.07 | 1.88 ± 0.23* | 1.54 ± 0.22 | 1.88 ± 0.21* |
5-HIAA (nmol/gm) | ||||
Frontal cortex | 1.52 ± 0.11 | 1.30 ± 0.04 | 1.20 ± 0.051-159 | 1.33 ± 0.08 |
Cingulate cortex | 0.77 ± 0.05 | 0.72 ± 0.04 | 0.70 ± 0.05 | 0.70 ± 0.04 |
HPLC analysis of the total tissue contents of 5-HT and 5-HIAA levels in frontal and cingulate cortex from adult wild-type littermates and trkB.T1 transgenic mice 3 hr after fluoxetine (20 mg/kg) or saline intraperitoneal injection. Data are shown as means ± SEM from five to six animals per group.
p < 0.05, indicating the significant difference of the treatment within the same genotype;
F1-159: p < 0.05, significantly different from wild type (Student's t test).